人民财讯8月11日电，希荻微(688173)8月11日晚间公告，公司董事、副总经理、核心技术人员范俊拟通 过集中竞价方式减持其持有的公司股份数量合计不超过300万股，占公司目前总股本的比例合计不超过 0.73%。 ...

智通财经APP获悉，华安证券发布研报称，德州仪器将在8月启动新一波涨价，幅度超过6月，若特定料 号TI涨价幅度较大，且国产模拟芯片厂商愿意维持价格(不跟进TI涨价)或进一步降价，则在一段时间验 证后的新品量产中也可进行国产替代，TI目前涨价将使得公司保障其现有财务表现但牺牲产品份额。该 行认为国产模拟芯片厂商将有更多机会实现在工业和汽车应用领域，以及高端消费领域的国产替代。 模拟芯片领域相关公司包括：思瑞浦(688536.SH)、杰华特(688141.SH)、圣邦股份(300661.SZ)、纳芯微 (688052.SH)、艾为电子(688798.SH)、希荻微(688173.SH)、必易微(688045.SH)、南芯科技(688484.SH) 等。 华安证券主要观点如下： 德州仪器料号涨价，幅度或将超过6月 根据国际电子商情综合报道，TI将在8月启动新一波涨价，幅度超过6月，重点涉及工控类、车载类、以 及算力相关芯片产品，覆盖LDO(低压差线性稳压器)、DC-DC(直流-直流转换器)、数字隔离、隔离驱动 等品类。而且调价范围不仅涉及终端客户，还覆盖了除超级大客户外的几乎所有客户群体，且价格上调 将通过代理商传 ...

证券代码：688173 证券简称：希荻微 公告编号：2025-063 二、本次限制行权期为 2025 年 8 月 15 日至 2025 年 8 月 29 日，在此期间全 部激励对象将限制行权。 三、公司将按照有关规定及时向中国证券登记结算有限责任公司上海分公司 申请办理限制行权的相关事宜。 特此公告。 提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 根据《上市公司股权激励管理办法》《希荻微电子集团股份有限公司 2024 年股票期权激励计划（草案）》及中国证券登记结算有限责任公司上海分公司关 于股票期权自主行权的相关规定，结合希荻微电子集团股份有限公司（以下简称 "公司"）2025 年半年度报告的披露计划，现对公司 2024 年股票期权激励计划 的限制行权时间公告如下： | 激励计划 | 行权期 | 行权代码 | | | 实际可行权期限 | | | --- | --- | --- | --- | --- | --- | --- | | 年股票期权激励计 2024 | 第一个行权期 | 1000000597 | 2 ...

格隆汇8月6日丨希荻微(688173.SH)在投资者互动平台表示，公司高度关注Al端侧应用发展趋势，并积 极与合作伙伴探索芯片产品的商业机会。公司高性能芯片产品已通过ODM厂商实现向雷鸟等国内科技 公司销售，应用于AI眼镜等终端，但销售数量和金额占比较小，请理性判断并注意投资风险。 ...

Investment Rating - The report indicates an "Overweight" rating for the industry, suggesting a positive outlook for the next six months [31]. Core Insights - The report highlights a total of 79 merger and acquisition (M&A) events during the period from July 28 to August 3, with 14 classified as significant M&A transactions. Out of these, 15 M&A events were completed, while no significant M&A transactions were finalized [10]. - Recent policy updates emphasize that government investment funds should not engage in public trading of stocks, except for M&A, directed placements, and strategic allocations. This aims to prevent the increase of local government hidden debts [7][8]. - The report notes that the restructuring index outperformed the Wind All A index by 1.07% during the specified period, indicating a strong performance in the restructuring sector [25]. Summary by Sections M&A Activity Overview - During the week of July 28 to August 3, there were 79 M&A events involving listed companies, with 2 failures. The significant M&A events included 14 transactions, with 15 completed [10][16]. Major M&A Updates - The report lists several major M&A transactions involving state-owned enterprises and private companies, with notable transactions including China Shipbuilding's acquisition of China Heavy Industry for approximately 11.52 billion CNY [14]. Control Changes - Four listed companies reported changes in actual control, with notable transitions including Renfu Pharmaceutical being taken over by the State-owned Assets Supervision and Administration Commission [19]. Market Performance - The restructuring index showed a positive trend, outperforming the broader market index, which reflects a favorable environment for M&A activities [25].

Group 1 - On August 1, the financing buy-in amount for Xidiwei was 0.13 billion, ranking 977th in the two markets [1] - On the same day, the financing repayment amount was 0.15 billion, resulting in a net sell of 1.5292 million [1] - Over the last three trading days, Xidiwei received financing buy-ins of 0.21 billion, 0.31 billion, and 0.13 billion respectively [1] Group 2 - On the same day, the short selling amount was 0.04 thousand shares, with a net sell of 0.04 thousand shares [1]

证券代码：688173 证券简称：希荻微 公告编号：2025-062 希荻微电子集团股份有限公司 关于 2024 年股票期权激励计划预留授予部分 第一个行权期自主行权实施公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 激励计划"）预留授予部分第一个行权期的行权条件已成就，同意符合行权条件 的 7 名激励对象在规定的行权期内采取自主行权的方式行权。现将有关事项说明 如下： 一、股权激励计划批准及实施情况 （一）股票期权激励计划方案及履行程序 审议通过了《关于拟订公司<2024 年股票期权激励计划（草案）>及其摘要的议 案》 《关于拟订公司<2024 年股票期权激励计划实施考核管理办法>的议案》以及 《关于拟订公司<2024 年股票期权激励计划首次授予激励对象名单>的议案》等 议案，并提交公司董事会审议。 ? 股票期权拟行权数量：54.90 万份 ? 行权股票来源：向激励对象定向发行的公司 A 股普通股股票 ? 行权安排：本激励计划预留授予部分第一个行权期为自相应部分授予之 日起 12 个月后的首个交易日 ...

证券代码：688173 证券简称：希荻微 公告编号：2025-062 希荻微电子集团股份有限公司 关于 2024 年股票期权激励计划预留授予部分 第一个行权期自主行权实施公告 希荻微电子集团股份有限公司（以下简称"公司"）于 2025 年 7 月 24 日召 开第二届董事会第二十四次会议、第二届监事会第二十次会议，审议通过了《关 于 2024 年股票期权激励计划预留授予部分第一个行权期行权条件成就的议案》， 认为公司《2024 年股票期权激励计划（草案）》（以下简称"《激励计划》"或"本 激励计划"）预留授予部分第一个行权期的行权条件已成就，同意符合行权条件 的 7 名激励对象在规定的行权期内采取自主行权的方式行权。现将有关事项说明 如下： 股票期权拟行权数量：54.90 万份 行权股票来源：向激励对象定向发行的公司 A 股普通股股票 一、股权激励计划批准及实施情况 （一）股票期权激励计划方案及履行程序 1. 2024 年 3 月 7 日，公司召开第二届董事会薪酬与考核委员会第二次会议， 审议通过了《关于拟订公司<2024 年股票期权激励计划（草案）>及其摘要的议 案》《关于拟订公司<2024 年股票期权激励 ...

Macro Strategy - The chemical sector has seen continuous catalysts on both supply and demand sides since 2024, with the current "anti-involution" trend enhancing the market outlook, driven by a favorable fundamental environment and potential valuation uplift from emerging industries [1][23] - More than half of the existing convertible bonds in the chemical sector are issued at the peak of the cycle, currently entering or about to enter the redemption period, coinciding with an upward cycle, leading to more proactive debt conversion measures [1][23] - The majority of chemical convertible bonds are small-cap, which, combined with their near-term characteristics, amplifies the asymmetry of returns [1][23] Currency Exchange Rate - The RMB central parity has shown a gradual appreciation trend, with the exchange rate expected to challenge the 7.15 range again, and the spot exchange rate may drop to the 7.10-7.15 range in August [1][25] - The recent strengthening of the RMB is supported by optimistic expectations from US-China trade negotiations and a robust domestic stock market [1][25] Anti-Involution Policy - The "anti-involution" price governance aims to address three main objectives: short-term regulation of price wars, medium-term capacity reduction to promote supply-demand balance, and long-term price recovery, particularly in PPI [2][26] - The previous supply-side reforms led to a 10-month recovery in PPI, and under neutral assumptions, a similar recovery may take 11-12 months, potentially reaching around 1.9% by September next year [2][26] Industry Rotation - The market is expected to remain optimistic in the third quarter, with a focus on sectors that align with upcoming policies and key events, particularly those benefiting from the "anti-involution" strategy [3][5] - Suggested sectors for investment include those with potential short-term demand improvements, such as photovoltaic, coal, and chemical industries, as well as technology sectors with recent catalysts [5][3] Company-Specific Insights - Xidi Microelectronics is positioned as a leading player in the analog chip sector, with a projected revenue growth of 32.10% year-on-year for the first three quarters of 2024, driven by significant contributions from its audio coil motor driver chip product line [11][12] - Minshida reported a 27.91% year-on-year revenue increase in its 2025 mid-year report, with expectations for continued growth in the transformer market driven by demand from sectors like new energy vehicles and wind power [13] - Gaomei's second-quarter performance is expected to turn profitable due to supply-side optimization driven by the "anti-involution" policy, with N-type silicon wafer prices rising to 1.1 yuan per piece [14][15]

Core Viewpoint - The company Xidiwei (688173.SH) faces potential loss of control over its subsidiary Zinitix due to alleged misconduct by current directors, which could significantly impact its financial performance and reporting [1][4]. Group 1: Acquisition and Control Issues - Xidiwei acquired a 35.31% stake in Zinitix for approximately 1.12 million RMB in August 2024, forming a goodwill of 0.64 million RMB [2][5]. - The company has initiated legal actions against Zinitix's current directors for alleged theft of trade secrets and other misconduct, while facing resistance in convening a shareholder meeting to elect new directors [4][6]. - If Xidiwei loses control over Zinitix, it will cease to consolidate Zinitix in its financial statements, leading to a potential significant adverse impact on its 2025 financial results [4]. Group 2: Financial Performance and Challenges - Xidiwei has reported cumulative losses of approximately 3.6 million RMB over the past three years, with continued losses expected in Q1 2025 [1][8]. - Despite the losses, the chairman's salary has increased significantly, from approximately 1.6 million RMB in 2021 to over 2.2 million RMB in subsequent years [8]. - The company has been actively pursuing acquisitions to turn around its performance, including a recent announcement to acquire Chengxin Micro for a premium of 214.37% [8]. Group 3: Research and Development Investment - Xidiwei has consistently increased its R&D investment from 1.5 million RMB in 2021 to 2.53 million RMB in 2024, with R&D expenses accounting for 46.34% of its revenue in 2024 [9].